Yingling Zu
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Secondary malignancies after chronic myeloid leukaemia upon TKI treatment: Population trends and outcomes.
Journal: British journal of haematology
Published: April 05, 2025
Cord blood therapy for pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: case series and review.
Journal: Frontiers in oncology
Published: February 28, 2025
Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases.
Journal: Blood cancer journal
Published: November 26, 2024
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies.
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies.
Journal: Experimental hematology & oncology
Published: July 10, 2024
Outcome after short exposure to tyrosine kinase inhibitors in pregnant female patients with chronic myeloid leukemia.
Journal: Journal of hematology & oncology
Published: July 08, 2024
Vedolizumab for second-line treatment of steroid-refractory gastrointestinal late acute graft-versus-host disease.
Journal: Therapeutic advances in hematology
Published: April 17, 2024
Multiple small-dose infusions of G-CSF-mobilized haploidentical lymphocytes after autologous haematopoietic stem cell transplantation for acute myeloid leukaemia.
Journal: British journal of haematology
Published: December 25, 2023
Single VHH-directed BCMA CAR-NK cells for multiple myeloma.
Journal: Experimental hematology & oncology
Published: November 06, 2023
Sulforaphene suppresses oesophageal cancer growth through mitogen- and stress-activated kinase 2 in a PDX mouse model.
Journal: American journal of cancer research
Published: May 10, 2023
A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy.
Journal: Frontiers in oncology
Published: February 09, 2023
Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial.
Journal: Blood cancer journal
Published: November 08, 2022
Last Updated: 09/26/2026